Targeted anti-cancer therapies

A European Training Networks

About Us

TACT is a four-year project which aims at developing next treatments against cancer.
We aim to bring together academic and industrial institutions with diverse disciplinary backgrounds to work on training the next generation of scientists and equip them with transferable, future career-enhancing skills in order to create new European experts in the fight against cancer.

TACT recruited and currently train early-stage PhD students in the development of state-of-the-art targeted anti-cancer therapeutics via carefully designed research projects and participation to several network-wide meetings, offering a comprehensive training in various scientific and non-scientific areas.

Research and Innovation in Europe


The TACT project results from the collaboration between six universities and three companies located in five different European countries.

Our press

Lastest News

Read our latest news and consult our newsletters from academics across the Europe.

Follow us on Twitter

This is your chance to emphasize why the visitor should contact you right now.

2 PhD studentships to work on late-stage fluorination of proteins for PET imaging available! Bioconjugation, protein design & imaging studies in vivo. Students will be part of an exciting ITN network @ISOBIOTICSeuDN @MSCActions and will have industrial secondments @IMMolecular

Throwback to a great week spent in Belfast for the TACT consortium! A big thanks to @QubPGJCCR for their warm welcome and the interesting workshops organised throughout the week, ending with the presentations of the ESRs' latest work. Very enriching! 👏🧑‍🔬@MSCActions

Load More
Back to Top